The robotics giant’s most advanced soft tissue surgical system is now available for use in Europe across a range of ...

Intuitive Surgical Stock Jumps. ‘Da Vinci’ Robots Guide the Future. ... marking a 17% increase from the prior year and sailing above analysts’ calls for $8.15 billion.

Intuitive Surgical's growth remains strong, supported by solid procedure growth and the da Vinci 5 rollout. Click here to ...

Intuitive Surgical reports third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion. Intuitive Surgical reports third-quarter adjusted earnings of $1.84 per share ...

Instead, Intuitive Surgical may wait to see how the stock progresses this year -- it's already climbed about 15% since the start of January. And Intuitive Surgical has a big catalyst to keep this ...

Intuitive Surgical (NASDAQ: ISRG) has seen solid gains of over 80% from levels of around $270 in early January 2021 to nearly $500 now, vs. an increase of about 50% for the S&P 500 over this period.

Intuitive reported an 18% increase in procedure volume compared to last year's third quarter, ... Intuitive Surgical stock surges 10% amid da Vinci 5 demand, with full rollout set for 2025.

Intuitive Surgical beat profit and sales forecasts on higher demand for its minimally invasive da Vinci surgical devices. The company reported an 18% year-over-year increase in da Vinci procedures ...

Let's discuss whether Intuitive Surgical stock is a buy now. For the period ended Dec. 31, the medical technologies (medtech) giant delivered adjusted earnings per share (EPS) ...

During its second-quarter 2024 earnings call, Intuitive Surgical reported a 14% year-over-year increase in the installed base of da Vinci systems. The utilization rate, measured by procedures per ...

Intuitive Surgical (Nasdaq: ISRG) announced today that it received CE mark for its da Vinci 5 surgical robotic system.